• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 99-113 of 131 results

1017 Exhibit: Ex 1017 US Application No 11520,479, Non Final Office Action mailed...

Document IPR2017-01100, No. 1017 Exhibit - Ex 1017 US Application No 11520,479, Non Final Office Action mailed Mar 30, 2010 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1004 Exhibit: Ex 1004 Shively, US Patent No 5,407,683

Document IPR2017-01100, No. 1004 Exhibit - Ex 1004 Shively, US Patent No 5,407,683 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1018 Exhibit: Ex 1018 US Application No 11520,479, Amendment in Response to N...

Document IPR2017-01100, No. 1018 Exhibit - Ex 1018 US Application No 11520,479, Amendment in Response to Non Final Office Action dated Sept 30, 2010 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1005 Exhibit: Ex 1005 Liversidge et al, US Patent No 5,399,363

Document IPR2017-01100, No. 1005 Exhibit - Ex 1005 Liversidge et al, US Patent No 5,399,363 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1014 Exhibit: Ex 1014 Grinstaff et al, US Patent No 5,498,421

Document IPR2017-01100, No. 1014 Exhibit - Ex 1014 Grinstaff et al, US Patent No 5,498,421 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1001 Exhibit: Ex 1001 Desai et al, US Patent No 8,853,260 B2

Document IPR2017-01100, No. 1001 Exhibit - Ex 1001 Desai et al, US Patent No 8,853,260 B2 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

2030 Exhibit: Exhibit 2030

Document IPR2017-01100, No. 2030 Exhibit - Exhibit 2030 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

2018 Exhibit: Exhibit 2018

Document IPR2017-01100, No. 2018 Exhibit - Exhibit 2018 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

1008 Exhibit: Ex 1008 Physicians Desk Reference 307, 682 85 49th ed 1995 Taxolp...

Document IPR2017-01100, No. 1008 Exhibit - Ex 1008 Physicians Desk Reference 307, 682 85 49th ed 1995 Taxolpaclitaxel for Injection Concentrate (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1020 Exhibit: Ex 1020 US Application No 11520,479, Amendment After Final Action...

Document IPR2017-01100, No. 1020 Exhibit - Ex 1020 US Application No 11520,479, Amendment After Final Action Under 37 CFR 1114 dated Jan 27, 2012 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1030 Exhibit: Ex 1030 FDA, Approved Drug Products with Therapeutic Equivalence...

Document IPR2017-01100, No. 1030 Exhibit - Ex 1030 FDA, Approved Drug Products with Therapeutic Equivalence Evaluations 33d ed 2013 Orange Book (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1027 Exhibit: Ex 1027 List et al, US Patent No 5,389,382

Document IPR2017-01100, No. 1027 Exhibit - Ex 1027 List et al, US Patent No 5,389,382 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1022 Exhibit: Ex 1022 US Application No 11520,479, Non Final Office Action dated...

Document IPR2017-01100, No. 1022 Exhibit - Ex 1022 US Application No 11520,479, Non Final Office Action dated May 2, 2013 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1015 Exhibit: Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspe...

Document IPR2017-01100, No. 1015 Exhibit - Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspension paclitaxel protein bound particles for injectable suspension albumin bound revise...

cite Cite Document
Analyze

1028 Exhibit: Ex 1028 Liversidge et al, US Patent No 5,145,684

Document IPR2017-01100, No. 1028 Exhibit - Ex 1028 Liversidge et al, US Patent No 5,145,684 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 7 8 9 10 >>